Choksi Laboratories (CHOKSILA) | Financial Analysis & Statements
Financial Overview
Latest Annual: 2025Income Metrics
Revenue
417.8M
Gross Profit
345.9M
82.80%
Operating Income
48.0M
11.49%
Net Income
15.2M
3.65%
Balance Sheet Metrics
Total Assets
653.3M
Total Liabilities
417.3M
Shareholders Equity
236.0M
Debt to Equity
1.77
Cash Flow Metrics
Operating Cash Flow
51.4M
Free Cash Flow
40.9M
Revenue & Profitability Trend
Choksi Laboratories Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 417.8M | 367.0M | 344.4M | 300.4M | 256.9M |
| Cost of Goods Sold | 71.9M | 37.2M | 33.8M | 28.3M | 35.1M |
| Gross Profit | 345.9M | 329.7M | 310.6M | 272.1M | 221.8M |
| Operating Expenses | 63.8M | 74.8M | 68.1M | 58.0M | 59.0M |
| Operating Income | 48.0M | 47.2M | 49.5M | 36.6M | -3.0M |
| Pre-tax Income | 21.5M | 16.6M | 37.2M | 3.7M | -28.1M |
| Income Tax | 6.3M | 5.5M | 5.1M | 1.6M | -2.0M |
| Net Income | 15.2M | 11.1M | 32.1M | 2.1M | -26.1M |
| EPS (Diluted) | - | ₹1.59 | ₹4.61 | ₹0.30 | -₹3.74 |
Income Statement Trend
Choksi Laboratories Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 163.2M | 145.7M | 139.5M | 140.1M | 130.3M |
| Non-Current Assets | 490.1M | 473.8M | 464.2M | 504.1M | 533.5M |
| Total Assets | 653.3M | 619.5M | 603.6M | 644.2M | 663.8M |
| Liabilities | |||||
| Current Liabilities | 238.8M | 188.5M | 125.1M | 155.2M | 162.2M |
| Non-Current Liabilities | 178.5M | 208.9M | 267.4M | 309.9M | 324.1M |
| Total Liabilities | 417.3M | 397.4M | 392.6M | 465.1M | 486.3M |
| Equity | |||||
| Total Shareholders Equity | 236.0M | 222.1M | 211.1M | 179.0M | 177.5M |
Balance Sheet Composition
Choksi Laboratories Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 21.5M | 16.6M | 37.2M | 3.7M | -28.1M |
| Operating Cash Flow | 51.4M | 36.6M | 35.0M | 16.6M | -8.8M |
| Investing Activities | |||||
| Capital Expenditures | -74.4M | -69.1M | -7.1M | -26.4M | -80.5M |
| Investing Cash Flow | -74.2M | -67.2M | -7.0M | -26.4M | -80.5M |
| Financing Activities | |||||
| Dividends Paid | - | - | - | - | - |
| Financing Cash Flow | -10.5M | -11.1M | -36.6M | -14.5M | 36.1M |
| Free Cash Flow | 40.9M | 44.6M | 41.0M | 50.1M | -22.0M |
Cash Flow Trend
Choksi Laboratories Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
74.11
Price to Book
4.80
Price to Sales
2.73
Profitability Ratios
Profit Margin
3.65%
Operating Margin
15.76%
Return on Equity
6.65%
Return on Assets
4.65%
Financial Health
Current Ratio
0.68
Debt to Equity
123.52
Beta
-0.15
Per Share Data
EPS (TTM)
₹2.19
Book Value per Share
₹33.82
Revenue per Share
₹60.07
Financial data is updated regularly. All figures are in the company's reporting currency.